Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023PRNewsWire • 01/10/23
Illumina's Woes Mount As Guidance Lags And Grail Controversy ContinuesInvestors Business Daily • 01/10/23
Illumina, Inc. (ILMN) Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/10/23
Grail Introduces State-of-the-Art Methylation-Based Solution to Accelerate Cancer Research in the Post-Diagnosis SettingBusiness Wire • 01/09/23
Point32Health and GRAIL Expand Galleri® Multi-Cancer Early Detection Blood Test Pilot to Harvard Pilgrim Health Care Members on the Maine Health Insurance MarketplaceBusiness Wire • 12/15/22
Illumina: Strong EPS Growth Expected, But Shares Richly Valued In A Risky SpaceSeeking Alpha • 12/09/22
Illumina, Inc. (ILMN) Presents at Piper Sandler 34th Annual Healthcare Conference (Transcript)Seeking Alpha • 11/30/22
Illumina, Inc. (ILMN) Presents at Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • 11/29/22
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early DetectionBusiness Wire • 11/17/22
Illumina Plummets On Light Earnings Guidance Despite Quarterly BeatInvestors Business Daily • 11/03/22